Inventor · disambiguated record
Daniel Walker
Also filed as: WALKER DANIEL P · WALKER DANIEL PATRICK
22 granted patents·20 pending applications·436 citations·filing 1995–2020
96Inventor score
Top patents by PatentIndex Score
42 records- 0195US6919359B2Azabicyclic-substituted-heteroaryl compounds for the treatment of diseasePFIZER·Filed 2002·Granted Jul 19, 2005·61 cites·23 claims
- 0294US6911543B2Azabicyclic-substituted fused-heteroaryl compounds for the treatment of diseasePFIZER·Filed 2002·Granted Jun 28, 2005·71 cites·15 claims
- 0393US7001900B2Azabicyclic compounds for the treatment of diseasePFIZER·Filed 2003·Granted Feb 21, 2006·74 cites·5 claims
- 0493US6849620B2N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of diseasePFIZER·Filed 2002·Granted Feb 1, 2005·48 cites·31 claims
- 0591US6828330B2Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of diseaseUPJOHN CO·Filed 2002·Granted Dec 7, 2004·44 cites·63 claims
- 0689US9856201B23,6-dichlorosalicylic acid compounds and related synthetic processesMONSANTO TECHNOLOGY LLC·Filed 2015·Granted Jan 2, 2018·3 cites·20 claims
- 0788US10519092B23,6-dichlorosalicylic acid compounds and related synthetic processesMONSANTO TECHNOLOGY LLC·Filed 2017·Granted Dec 31, 2019·2 cites·18 claims
- 0885US7829572B2Pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as calcium receptor antagonistsPFIZER·Filed 2007·Granted Nov 9, 2010·8 cites·22 claims
- 0985US5965595A2-Imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonistsPROCTER & GAMBLE·Filed 1996·Granted Oct 12, 1999·38 cites·19 claims
- 1081US10266513B2Bruton's tyrosine kinase inhibitorsPFIZER·Filed 2017·Granted Apr 23, 2019·2 cites·6 claims
- 1181US5914342A2-imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonistsPROCTER & GAMBLE·Filed 1998·Granted Jun 22, 1999·28 cites·20 claims
- 1279US6951868B2Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of diseasePFIZER·Filed 2002·Granted Oct 4, 2005·14 cites·34 claims
- 1379US6894042B2Azabicyclic compounds for the treatment of diseaseUPJOHN CO·Filed 2003·Granted May 17, 2005·12 cites·14 claims
- 1477US7176198B21H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of diseasePFIZER·Filed 2003·Granted Feb 13, 2007·9 cites·11 claims
- 1576US10807936B23,6-dichlorosalicylic acid compounds and related synthetic processesMONSANTO TECHNOLOGY LLC·Filed 2019·Granted Oct 20, 2020·0 cites·11 claims
- 1673US10239857B2Processes for the preparation of 2-thiophenecarbonyl chlorideMONSANTO TECHNOLOGY LLC·Filed 2016·Granted Mar 26, 2019·1 cites·19 claims
- 1772US6858613B2Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of diseasePFIZER·Filed 2003·Granted Feb 22, 2005·5 cites·5 claims
- 1872US6852716B2Substituted-aryl compounds for treatment of diseasePFIZER·Filed 2003·Granted Feb 8, 2005·6 cites·12 claims
- 1968US2021002251A1Bruton's Tyrosine Kinase InhibitorsPFIZER·Filed 2020·Application pending·0 cites
- 2066US10815213B2Bruton's tyrosine kinase inhibitorsPFIZER·Filed 2019·Granted Oct 27, 2020·0 cites·4 claims
- 2165US10745376B2Processes for the preparation of heteroaryl carboxylic acidsMONSANTO TECHNOLOGY LLC·Filed 2017·Granted Aug 18, 2020·0 cites·19 claims
- 2264US5663189A2-imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonistsPROCTER & GAMBLE·Filed 1995·Granted Sep 2, 1997·10 cites·22 claims
- 2361US2020347026A1Processes for the preparation of heteroaryl carboxylic acidsMONSANTO TECHNOLOGY LLC·Filed 2020·Application pending·0 cites
- 2459US2015291554A1Bruton's Tyrosine Kinase InhibitorsPFIZER·Filed 2013·Application pending·0 cites
- 2558US2004249150A1Positive allosteric modulators of the nicotinic acetylcholine receptorPFIZER·Filed 2004·Application pending·0 cites
- 2658US2004254373A1Positive allosteric modulators of the nicotinic acetylcholine receptorPFIZER·Filed 2004·Application pending·0 cites
- 2757US2005250816A1Positive allosteric modulators of the nicotinic acetylcholine receptorPFIZER·Filed 2005·Application pending·0 cites
- 2854US2005215584A1Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of diseasePFIZER·Filed 2004·Application pending·0 cites
- 2954US2003236287A1Positive allosteric modulators of the nicotinic acetylcholine receptorFiled 2003·Application pending·0 cites
- 3054US2005222196A1Azabicyclic-substituted fused heteroaryl compounds for the treatment of diseasePFIZER·Filed 2005·Application pending·0 cites
- 3154US2005234092A1Azabicyclic-substituted fused heteroaryl compounds for the treatment of diseasePFIZER·Filed 2005·Application pending·0 cites
- 3253US2004224976A1Azabicyclic compounds for the treatment of diseaseFiled 2004·Application pending·0 cites
- 3352US2006116395A11H-pyrazole and 1h-pyrole-azabicyclic compounds for the treatment of diseasePFIZER·Filed 2006·Application pending·0 cites
- 3450US2004224977A1Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of diseaseFiled 2004·Application pending·0 cites
- 3548US6869946B2Substituted azabicyclic moieties for the treatment of diseasePFIZER·Filed 2002·Granted Mar 22, 2005·0 cites·14 claims
- 3648US2005107425A1Treatment of attention defecit hyperactivity disorderPFIZER·Filed 2004·Application pending·0 cites
- 3745US2004147522A1Compounds having both alpha7 nicotinic agonist activity and 5HT3 antagonist activity for the treatment of CNS diseasesFiled 2003·Application pending·0 cites
- 3845US2006173063A1Exo-(t-butyl 2R(+))-2-amino-7-azabicyclo[2.2.1]heptane-7-carboxylate, intermediates, and process to prepare and isolate themPFIZER·Filed 2004·Application pending·0 cites
- 3943US2005059698A1Quinuclidines-substituted-multi-cyclic-heteroaryls for treatment of diseasePFIZER·Filed 2004·Application pending·0 cites
- 4043US2004157878A1Compounds as radioligands for the diagnosis of diseaseFiled 2003·Application pending·0 cites
- 4143US2011028452A1PYRIDO[4,3-d]PYRIMIDIN-4(3H)-ONE DERIVATIVES AS CALCIUM RECEPTOR ANTAGONISTSPFIZER·Filed 2010·Application pending·0 cites
- 4239US2003105089A1Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of diseaseFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Walker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →